Back
About the Global Fund
Sixth Replenishment
People & Structures
Funding Model
�Investments & Results
-
Explore our data on investments and results in the fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
- Find a Grant (Old Grant Portfolio)
HIV & AIDS
Tuberculosis
MalariaNews & Stories
-
24 August 2019
European Union Announces Major Increase to the Global Fund -
22 August 2019
Canada Steps Up Fight Against Epidemics with a Major Increase to Global Fund -
12 June 2019
Our Global Health Security is Only as Strong as our Weakest Link -
06 June 2019
Morocco: “Civil Society is Helping Us Reach Key Populations” -
More News & Stories
-
Newsroom & Media Contacts
Feature Stories
Updates
- European Union Announces Major Increase to the Global Fund
- Canada Steps Up Fight Against Epidemics with a Major Increase to Global Fund
- Seventh Tokyo International Conference on African Development (TICAD7) Guide
- Switzerland Increases Contribution to Global Fund
- Patricia Moser Elected Chair of Technical Review Panel
-
More Updates
Featured Publication
Documents By Type
Sourcing & Management of Health Products
Withdrawal of the Quality Assurance Information Notice 2016-02 regarding IPCA Ratlam Manufacturing Site
15 July 2019
The Quality Assurance Information Notice 2016-02 providing recommendations regarding the procurement and the distribution of finished pharmaceutical products using active pharmaceutical ingredients manufactured at IPCA Ratlam Manufacturing Site is withdrawn. This is to reflect the Sourcing and Supply Chain Department decision that no specific quality assurance requirements are currently implemented by Global Fund quality assurance on IPCA finished pharmaceuticals products.